Check Cap Stock

Check Cap Equity Growth

The Year-over-Year Equity Growth of Check Cap (MBAI) as of Aug 15, 2026 is 337.03 %. In the previous year, Year-over-Year Equity Growth was -106.12 % — a change of -417.59% (higher).

Equity Growth

337.03 %

YoY

-417.59%

Last updated:

Year-over-Year Equity Growth of Check Cap is 2026 337.03 % . Year-over-Year Equity Growth of Check Cap was 2025 -106.12 % . It decreases by -417.59% higher compared to the previous year.
Access this data via the Eulerpool API

Check Cap Stock analysis

What does Check Cap do? Check Cap Ltd is an international biotech company specializing in the development of non-invasive diagnostic technologies for early detection of colon cancer. The company is headquartered in Israel and was founded in 2004. Check Cap is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Check Cap stock

Year-over-Year Equity Growth of Check Cap is 337.03 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Check Cap since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Check Cap historically and in real time.

Access this data via the Eulerpool API

Growth — Check Cap

All Key Metrics — Check Cap